_id
69148eefccc777a4e85d9b87
Ticker
PMVP
Name
Pmv Pharmaceuticals Inc
Exchange
NASDAQ
Address
400 Alexander Park Drive, Princeton, NJ, United States, 08540
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.pmvpharma.com
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Last Close
1.25
Volume
339575
Current Price
1.23
Change
-1.6000000000000014
Last Updated
2025-12-03T12:13:43.251Z
Image
-
Ipo Date
2020-09-25T00:00:00.000Z
Market Cap
65450156
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.4325
Sentiment Sources
2
Rating
4.8
Target Price
7.6
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
32000
Gross Profit
-32000
Operating Expenses
22490000
Operating Income
-22522000
Interest Expense
-
Pretax Income
-21065000
Net Income
-21059000
Eps
-0.3973903236484625
Dividends Per Share
-
Shares Outstanding
53211507
Income Tax Expense
-6000
EBITDA
-21033000
Operating Margin
-
Total Other Income Expense Net
1457000
Cash
36337000
Short Term Investments
92913000
Receivables
-
Inventories
-
Total Current Assets
132449000
Property Plant Equipment
1146000
Total Assets
133844000
Payables
3399000
Short Term Debt
390000
Long Term Debt
-
Total Liabilities
12845000
Equity
120999000
Depreciation
32000
Change In Working Capital
522000
Cash From Operations
-19820000
Capital Expenditures
1000
Cash From Investing
12028000
Cash From Financing
0
Net Change In Cash
-7790000
PE
-
PB
0.5386960449259911
ROE
-17.40427606839726
ROA
-15.733988822808643
FCF
-19821000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
6.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
32000
Quarters > 0 > income Statement > gross Profit
-32000
Quarters > 0 > income Statement > operating Expenses
22490000
Quarters > 0 > income Statement > operating Income
-22522000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-21065000
Quarters > 0 > income Statement > net Income
-21059000
Quarters > 0 > income Statement > eps
-0.3973903236484625
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
52993238
Quarters > 0 > income Statement > income Tax Expense
-6000
Quarters > 0 > income Statement > EBITDA
-21033000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1457000
Quarters > 0 > balance Sheet > cash
36337000
Quarters > 0 > balance Sheet > short Term Investments
92913000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
132449000
Quarters > 0 > balance Sheet > property Plant Equipment
1146000
Quarters > 0 > balance Sheet > total Assets
133844000
Quarters > 0 > balance Sheet > payables
3399000
Quarters > 0 > balance Sheet > short Term Debt
390000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
12845000
Quarters > 0 > balance Sheet > equity
120999000
Quarters > 0 > cash Flow > net Income
-21059000
Quarters > 0 > cash Flow > depreciation
32000
Quarters > 0 > cash Flow > change In Working Capital
522000
Quarters > 0 > cash Flow > cash From Operations
-19820000
Quarters > 0 > cash Flow > capital Expenditures
1000
Quarters > 0 > cash Flow > cash From Investing
12028000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-7790000
Quarters > 0 > ratios > PE
-0.3973903236484625
Quarters > 0 > ratios > PB
0.5386960449259911
Quarters > 0 > ratios > ROE
-17.40427606839726
Quarters > 0 > ratios > ROA
-15.733988822808643
Quarters > 0 > ratios > FCF
-19821000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
32000
Quarters > 1 > income Statement > gross Profit
-32000
Quarters > 1 > income Statement > operating Expenses
22847000
Quarters > 1 > income Statement > operating Income
-22879000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-21205000
Quarters > 1 > income Statement > net Income
-21210000
Quarters > 1 > income Statement > eps
-0.4077997067802825
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
52010827
Quarters > 1 > income Statement > income Tax Expense
5000
Quarters > 1 > income Statement > EBITDA
-21173000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1674000
Quarters > 1 > balance Sheet > cash
44127000
Quarters > 1 > balance Sheet > short Term Investments
98147000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
145311000
Quarters > 1 > balance Sheet > property Plant Equipment
1264000
Quarters > 1 > balance Sheet > total Assets
152855000
Quarters > 1 > balance Sheet > payables
2598000
Quarters > 1 > balance Sheet > short Term Debt
377000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
12250000
Quarters > 1 > balance Sheet > equity
140605000
Quarters > 1 > cash Flow > net Income
-21210000
Quarters > 1 > cash Flow > depreciation
32000
Quarters > 1 > cash Flow > change In Working Capital
1914000
Quarters > 1 > cash Flow > cash From Operations
-18302000
Quarters > 1 > cash Flow > capital Expenditures
11000
Quarters > 1 > cash Flow > cash From Investing
10986000
Quarters > 1 > cash Flow > cash From Financing
103000
Quarters > 1 > cash Flow > net Change In Cash
-7214000
Quarters > 1 > ratios > PE
-0.4077997067802825
Quarters > 1 > ratios > PB
0.4549860759574695
Quarters > 1 > ratios > ROE
-15.084812062159953
Quarters > 1 > ratios > ROA
-13.875895456478363
Quarters > 1 > ratios > FCF
-18313000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
21564000
Quarters > 2 > income Statement > operating Income
-21564000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-19633000
Quarters > 2 > income Statement > net Income
-17436000
Quarters > 2 > income Statement > eps
-0.33561749307052663
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
51952000
Quarters > 2 > income Statement > income Tax Expense
-2197000
Quarters > 2 > income Statement > EBITDA
-21527000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1931000
Quarters > 2 > balance Sheet > cash
51341000
Quarters > 2 > balance Sheet > short Term Investments
109047000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
163499000
Quarters > 2 > balance Sheet > property Plant Equipment
1437000
Quarters > 2 > balance Sheet > total Assets
170608000
Quarters > 2 > balance Sheet > payables
3593000
Quarters > 2 > balance Sheet > short Term Debt
364000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10501000
Quarters > 2 > balance Sheet > equity
160107000
Quarters > 2 > cash Flow > net Income
-17436000
Quarters > 2 > cash Flow > depreciation
37000
Quarters > 2 > cash Flow > change In Working Capital
-1535000
Quarters > 2 > cash Flow > cash From Operations
-18266000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
28714000
Quarters > 2 > cash Flow > cash From Financing
10000
Quarters > 2 > cash Flow > net Change In Cash
10465000
Quarters > 2 > ratios > PE
-0.33561749307052663
Quarters > 2 > ratios > PB
0.39911409245067364
Quarters > 2 > ratios > ROE
-10.89021716726939
Quarters > 2 > ratios > ROA
-10.219919347275626
Quarters > 2 > ratios > FCF
-18270000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
25168000
Quarters > 3 > income Statement > operating Income
-25168000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-23000000
Quarters > 3 > income Statement > net Income
-23000000
Quarters > 3 > income Statement > eps
-0.4459609097424174
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
51574027
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-25129000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2168000
Quarters > 3 > balance Sheet > cash
40876000
Quarters > 3 > balance Sheet > short Term Investments
128578000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
175658000
Quarters > 3 > balance Sheet > property Plant Equipment
1552000
Quarters > 3 > balance Sheet > total Assets
191288000
Quarters > 3 > balance Sheet > payables
6579000
Quarters > 3 > balance Sheet > short Term Debt
352000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15208000
Quarters > 3 > balance Sheet > equity
176080000
Quarters > 3 > cash Flow > net Income
-23000000
Quarters > 3 > cash Flow > depreciation
39000
Quarters > 3 > cash Flow > change In Working Capital
1445000
Quarters > 3 > cash Flow > cash From Operations
-16661000
Quarters > 3 > cash Flow > capital Expenditures
56000
Quarters > 3 > cash Flow > cash From Investing
7744000
Quarters > 3 > cash Flow > cash From Financing
172000
Quarters > 3 > cash Flow > net Change In Cash
-8756000
Quarters > 3 > ratios > PE
-0.4459609097424174
Quarters > 3 > ratios > PB
0.360268362164925
Quarters > 3 > ratios > ROE
-13.062244434348024
Quarters > 3 > ratios > ROA
-12.023754757224708
Quarters > 3 > ratios > FCF
-16717000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1144000
Annuals > 0 > income Statement > gross Profit
-1144000
Annuals > 0 > income Statement > operating Expenses
84304000
Annuals > 0 > income Statement > operating Income
-85448000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-74809000
Annuals > 0 > income Statement > net Income
-58709000
Annuals > 0 > income Statement > eps
-1.1382388119213382
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
51578807
Annuals > 0 > income Statement > income Tax Expense
-16100000
Annuals > 0 > income Statement > EBITDA
-73665000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
10639000
Annuals > 0 > balance Sheet > cash
40876000
Annuals > 0 > balance Sheet > short Term Investments
128578000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
175658000
Annuals > 0 > balance Sheet > property Plant Equipment
1552000
Annuals > 0 > balance Sheet > total Assets
191288000
Annuals > 0 > balance Sheet > payables
6579000
Annuals > 0 > balance Sheet > short Term Debt
352000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
15208000
Annuals > 0 > balance Sheet > equity
176080000
Annuals > 0 > cash Flow > net Income
-58709000
Annuals > 0 > cash Flow > depreciation
1144000
Annuals > 0 > cash Flow > change In Working Capital
-1592000
Annuals > 0 > cash Flow > cash From Operations
-51282000
Annuals > 0 > cash Flow > capital Expenditures
655000
Annuals > 0 > cash Flow > cash From Investing
53352000
Annuals > 0 > cash Flow > cash From Financing
313000
Annuals > 0 > cash Flow > net Change In Cash
2348000
Annuals > 0 > ratios > PE
-1.1382388119213382
Annuals > 0 > ratios > PB
0.36030175266924125
Annuals > 0 > ratios > ROE
-33.34223080417992
Annuals > 0 > ratios > ROA
-30.69141817573502
Annuals > 0 > ratios > FCF
-51937000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1257000
Annuals > 1 > income Statement > gross Profit
-1257000
Annuals > 1 > income Statement > operating Expenses
78875000
Annuals > 1 > income Statement > operating Income
-80132000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-68958000
Annuals > 1 > income Statement > net Income
-68960000
Annuals > 1 > income Statement > eps
-1.4362284673769847
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
48014645
Annuals > 1 > income Statement > income Tax Expense
2000
Annuals > 1 > income Statement > EBITDA
-67701000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
11174000
Annuals > 1 > balance Sheet > cash
37706000
Annuals > 1 > balance Sheet > short Term Investments
165351000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
207409000
Annuals > 1 > balance Sheet > property Plant Equipment
19048000
Annuals > 1 > balance Sheet > total Assets
252152000
Annuals > 1 > balance Sheet > payables
3237000
Annuals > 1 > balance Sheet > short Term Debt
852000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
26463000
Annuals > 1 > balance Sheet > equity
225689000
Annuals > 1 > cash Flow > net Income
-68960000
Annuals > 1 > cash Flow > depreciation
1257000
Annuals > 1 > cash Flow > change In Working Capital
5427000
Annuals > 1 > cash Flow > cash From Operations
-55657000
Annuals > 1 > cash Flow > capital Expenditures
962000
Annuals > 1 > cash Flow > cash From Investing
-50545000
Annuals > 1 > cash Flow > cash From Financing
35577000
Annuals > 1 > cash Flow > net Change In Cash
-70591000
Annuals > 1 > ratios > PE
-1.4362284673769847
Annuals > 1 > ratios > PB
0.26167874087793375
Annuals > 1 > ratios > ROE
-30.555321703760484
Annuals > 1 > ratios > ROA
-27.348583394143215
Annuals > 1 > ratios > FCF
-56619000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
650000
Annuals > 2 > income Statement > gross Profit
-650000
Annuals > 2 > income Statement > operating Expenses
77040000
Annuals > 2 > income Statement > operating Income
-77040000
Annuals > 2 > income Statement > interest Expense
4029000
Annuals > 2 > income Statement > pretax Income
-73326000
Annuals > 2 > income Statement > net Income
-73317000
Annuals > 2 > income Statement > eps
-1.6080114707757178
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
45594824
Annuals > 2 > income Statement > income Tax Expense
-9000
Annuals > 2 > income Statement > EBITDA
-76725000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
3714000
Annuals > 2 > balance Sheet > cash
108297000
Annuals > 2 > balance Sheet > short Term Investments
132757000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
247006000
Annuals > 2 > balance Sheet > property Plant Equipment
20494000
Annuals > 2 > balance Sheet > total Assets
270308000
Annuals > 2 > balance Sheet > payables
2996000
Annuals > 2 > balance Sheet > short Term Debt
528000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
24280000
Annuals > 2 > balance Sheet > equity
246028000
Annuals > 2 > cash Flow > net Income
-73317000
Annuals > 2 > cash Flow > depreciation
650000
Annuals > 2 > cash Flow > change In Working Capital
-568000
Annuals > 2 > cash Flow > cash From Operations
-63760000
Annuals > 2 > cash Flow > capital Expenditures
7984000
Annuals > 2 > cash Flow > cash From Investing
-1368000
Annuals > 2 > cash Flow > cash From Financing
958000
Annuals > 2 > cash Flow > net Change In Cash
-64170000
Annuals > 2 > ratios > PE
-1.6080114707757178
Annuals > 2 > ratios > PB
0.22794817467930478
Annuals > 2 > ratios > ROE
-29.80026663631782
Annuals > 2 > ratios > ROA
-27.123503558903177
Annuals > 2 > ratios > FCF
-71744000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1281000
Annuals > 3 > income Statement > gross Profit
-1281000
Annuals > 3 > income Statement > operating Expenses
58293000
Annuals > 3 > income Statement > operating Income
-58293000
Annuals > 3 > income Statement > interest Expense
777000
Annuals > 3 > income Statement > pretax Income
-57823000
Annuals > 3 > income Statement > net Income
-57846000
Annuals > 3 > income Statement > eps
-1.2815463877876156
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
45137656
Annuals > 3 > income Statement > income Tax Expense
23000
Annuals > 3 > income Statement > EBITDA
-57986000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
470000
Annuals > 3 > balance Sheet > cash
172467000
Annuals > 3 > balance Sheet > short Term Investments
124696000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
301286000
Annuals > 3 > balance Sheet > property Plant Equipment
13150000
Annuals > 3 > balance Sheet > total Assets
331568000
Annuals > 3 > balance Sheet > payables
3189000
Annuals > 3 > balance Sheet > short Term Debt
403000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
23009000
Annuals > 3 > balance Sheet > equity
308559000
Annuals > 3 > cash Flow > net Income
-57846000
Annuals > 3 > cash Flow > depreciation
1281000
Annuals > 3 > cash Flow > change In Working Capital
4123000
Annuals > 3 > cash Flow > cash From Operations
-46571000
Annuals > 3 > cash Flow > capital Expenditures
1349000
Annuals > 3 > cash Flow > cash From Investing
-143584000
Annuals > 3 > cash Flow > cash From Financing
2021999
Annuals > 3 > cash Flow > net Change In Cash
-188133000
Annuals > 3 > ratios > PE
-1.2815463877876156
Annuals > 3 > ratios > PB
0.17993095933030637
Annuals > 3 > ratios > ROE
-18.74714398218817
Annuals > 3 > ratios > ROA
-17.446195048979398
Annuals > 3 > ratios > FCF
-47920000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.3973903236484625
Valuation > metrics > PB
0.5386960449259911
Valuation > final Score
70
Valuation > verdict
46.1% Undervalued
Profitability > metrics > ROE
-17.40427606839726
Profitability > metrics > ROA
-15.899704792033159
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.10615790213142258
Risk > metrics > Interest Coverage
-703.8125
Risk > final Score
-2755
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.956188968065455
Liquidity > metrics > Quick Ratio
34.956188968065455
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-2800
Prev Risks > 1
14
Prev Risks > 2
13
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:13:20.329Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.4
Earnings History > 0 > eps Estimate
-0.4067
Earnings History > 0 > eps Difference
0.0067
Earnings History > 0 > surprise Percent
1.6474
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.41
Earnings History > 1 > eps Estimate
-0.39
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-5.1282
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.34
Earnings History > 2 > eps Estimate
-0.3833
Earnings History > 2 > eps Difference
0.0433
Earnings History > 2 > surprise Percent
11.2966
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.45
Earnings History > 3 > eps Estimate
-0.38
Earnings History > 3 > eps Difference
-0.07
Earnings History > 3 > surprise Percent
-18.4211
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.37
Earnings History > 4 > eps Estimate
-0.35
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-5.7143
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
-0.35
Earnings History > 5 > eps Difference
0.33
Earnings History > 5 > surprise Percent
94.2857
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.3
Earnings History > 6 > eps Estimate
-0.36
Earnings History > 6 > eps Difference
0.06
Earnings History > 6 > surprise Percent
16.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.31
Earnings History > 7 > eps Estimate
-0.39
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
20.5128
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.34
Earnings History > 8 > eps Estimate
-0.45
Earnings History > 8 > eps Difference
0.11
Earnings History > 8 > surprise Percent
24.4444
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.38
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
19.1489
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.42
Earnings History > 10 > eps Estimate
-0.46
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
8.6957
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-01
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.43
Earnings History > 11 > eps Estimate
-0.44
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
2.2727
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.4
Earnings History > 12 > eps Estimate
-0.42
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
4.7619
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.38
Earnings History > 13 > eps Estimate
-0.41
Earnings History > 13 > eps Difference
0.03
Earnings History > 13 > surprise Percent
7.3171
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.41
Earnings History > 14 > eps Estimate
-0.4
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-2.5
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-01
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.4
Earnings History > 15 > eps Estimate
-0.35
Earnings History > 15 > eps Difference
-0.05
Earnings History > 15 > surprise Percent
-14.2857
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.33
Earnings History > 16 > eps Estimate
-0.3
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-10
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.29
Earnings History > 17 > eps Estimate
-0.28
Earnings History > 17 > eps Difference
-0.01
Earnings History > 17 > surprise Percent
-3.5714
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-14
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.26
Earnings History > 18 > eps Estimate
-0.24
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-8.3333
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-03
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.23
Earnings History > 19 > eps Estimate
-0.57
Earnings History > 19 > eps Difference
0.34
Earnings History > 19 > surprise Percent
59.6491
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-13
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.46
Earnings History > 20 > eps Estimate
-0.34
Earnings History > 20 > eps Difference
-1.12
Earnings History > 20 > surprise Percent
-329.4118
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-25
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.48
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.48
Earnings History > 21 > surprise Percent
-
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7% – Here’s Why Defense World
Read more →PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.6
Analyst Picks
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 73.13% of the total shares of Pmv Pharmaceuticals Inc
1.
Orbimed Advisors, LLC(12.2196%)
since
2025/06/30
2.
BML Capital Management LLC(9.4356%)
since
2025/06/30
3.
Sio Capital Management, LLC(7.0491%)
since
2025/06/30
4.
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)(6.0164%)
since
2025/06/30
5.
Euclidean Capital LLC(4.9587%)
since
2025/06/30
6.
Alkeon Capital Management, LLC(4.4203%)
since
2025/06/30
7.
Vanguard Group Inc(4.0641%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.8154%)
since
2025/07/31
9.
Meridian Small Cap Growth Legacy(2.3692%)
since
2025/06/30
10.
ArrowMark Small Cap Gro(2.3692%)
since
2025/06/30
11.
ACAP Strategic A(2.1647%)
since
2025/06/30
12.
BlackRock Inc(2.1524%)
since
2025/06/30
13.
Stonepine Capital Management Llc(1.5964%)
since
2025/06/30
14.
D. E. Shaw & Co LP(1.2222%)
since
2025/06/30
15.
SQUAD Aguja Opportunities I(1.0757%)
since
2025/05/31
16.
Aldebaran Capital LLC(0.9721%)
since
2025/06/30
17.
Two Sigma Advisers, LLC(0.9166%)
since
2025/06/30
18.
Peapod Lane Capital LLC(0.8543%)
since
2025/06/30
19.
Geode Capital Management, LLC(0.8166%)
since
2025/06/30
20.
Vanguard Institutional Extnd Mkt Idx Tr(0.7005%)
since
2025/07/31
21.
Two Sigma Investments LLC(0.55%)
since
2025/06/30
22.
BlackRock Advantage Small Cap Core Instl(0.5292%)
since
2025/07/31
23.
Assenagon Asset Management SA(0.4964%)
since
2025/06/30
24.
Citadel Advisors Llc(0.4839%)
since
2025/06/30
25.
RBF LLC(0.4634%)
since
2025/06/30
26.
Fidelity Extended Market Index(0.3948%)
since
2025/07/31
27.
State Street Corp(0.2974%)
since
2025/06/30
28.
Bridgeway Capital Management, LLC(0.2808%)
since
2025/06/30
29.
iShares Micro-Cap ETF(0.1806%)
since
2025/08/31
30.
Extended Equity Market Fund K(0.1597%)
since
2025/06/30
31.
Fidelity Total Market Index(0.1355%)
since
2025/07/31
32.
Bridgeway Ultra-Small Company(0.1319%)
since
2025/06/30
33.
Invesco Technology S&P US Sel Sec ETF(0.1313%)
since
2025/07/31
34.
Fidelity Series Total Market Index(0.1148%)
since
2025/07/31
35.
Goldman Sachs Absolute Ret Trckr Instl(0.1112%)
since
2025/06/30
36.
Bridgeway Ultra-Small Company Market(0.1102%)
since
2025/06/30
37.
Spartan Extended Market Index Pool F(0.0952%)
since
2025/07/31
38.
Northern Trust Extended Eq Market Idx(0.095%)
since
2025/06/30
39.
NT Ext Equity Mkt Idx Fd - L(0.095%)
since
2025/06/30
40.
NT Ext Equity Mkt Idx Fd - NL(0.0862%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.4
EPS Estimate
-0.4067
EPS Difference
0.0067
Surprise Percent
1.6474%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.